Your browser doesn't support javascript.
loading
Hydroxocobalamin to treat refractory vasoplegia following phaeochromocytoma resection in a child.
Giustini, A J; Rowe, E V; Perez, F D; Mihm, F G.
Afiliação
  • Giustini AJ; Department of Anesthesiology Oregon Health and Science University Portland OR USA.
  • Rowe EV; Department of Anesthesiology Stanford University Stanford CA USA.
  • Perez FD; Department of Anesthesiology Stanford University Stanford CA USA.
  • Mihm FG; Department of Anesthesiology Stanford University Stanford CA USA.
Anaesth Rep ; 10(2): e12201, 2022.
Article em En | MEDLINE | ID: mdl-36523482
ABSTRACT
Phaeochromocytomas and paragangliomas are rare neuroendocrine tumours that often secrete catecholamines, which can cause dramatic swings in blood pressure and end-organ damage. During surgical resection of these tumours, antihypertensive drug infusions are often required, but after resection patients may become vasoplegic, in part due to cessation of catecholamine secretion by the tumour in the context of pre-operative α1 adrenoceptor antagonism. Numerous medications have been used to treat vasoplegia in this setting, including noradrenaline, vasopressin and, more recently, angiotensin II. We report the case of a patient who experienced vasoplegia after phaeochromocytoma resection which was refractory to vasopressin and angiotensin II infusions but was successfully treated with high dose hydroxocobalamin.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Anaesth Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Anaesth Rep Ano de publicação: 2022 Tipo de documento: Article
...